Cramer's Broker Plays2 Portfolio - Stockpickr! Your Source for Stock Ideas

Cramer's Broker Plays2

1396 views

TheStreet.com Rating: C-

Rate Now:

average rating: 0.00 / 0 ratings

printer friendly

send to a friend

Created by sarah z

DESCRIPTION:

Date updated:08-28-2007

From 8-28-07:

"Finally, the number cuts! Finally, the downgrades! People seem possessed when it comes to trying to call a bottom in the securities stocks. They know that these companies have tremendous earnings power and they seem dirt-cheap because of their high single-digit multiples. They know that despite the fact that August was one of the worst months in the history of this business, these companies have a way of turning themselves around quickly -- through rapid firings and downsizings where it is most needed -- and giving us quick earnings recoveries.

What drives these stocks are expectations, and the expectations for this group were all set when things were hitting on all cylinders: private equity, mortgage backs, fixed income, IPOs, corporate finance, mergers and acquisitions -- you name it, it was working. But for the past two months nothing's been working, yet the estimates stayed high and the stocks stayed on the recommended lists. Monday we got some much-needed number cuts from Goldman Sachs' research. At last, the bottoming can start.

LEH
Leh
$0.00
N/A
$N/A

No Analysis added

People owning LEH also tend to own: BNI CX EFA EWJ EWY GOOG IVE

TheStreet.com Rating: No Rating What is this?

BSC
Elements Bg Sm Cp
$10.04
0.00%
$N/A

No Analysis added

People owning BSC also tend to own: AAPL DE ERTS GROW LFC PBR ARNA

TheStreet.com Rating: D+ What is this?

GS
Goldman Sachs Grp
$171.78
-0.93%
$171.96

Goldman's not a cocky place, despite all appearances from the outside that it might be. The place has always run scared and underconfident, and Lloyd Blankfein is a great continuer of that tradition. That's what makes it entirely possible that Goldman's got something good up its sleeve.

People owning GS also tend to own: AOB COGO CRYP GEL GLW GRMN MDRX

TheStreet.com Rating: C What is this?

Comments not available

Top Do-It-Yourself Portfolios
» John Shier
» Joy
» tsamanuli Portfolio 1
» brueckenc Portfolio 1
» Fundsonly Portfolio 1
show all

Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM

'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM

Squeezing the Shorts: Late Earni...

By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...

11.04.09 | 15:18 PM

Cramer's Take on Headline Stocks...

By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...

11.04.09 | 11:12 AM

General market Technical Analysi...

11.14.07 | 22:55 PM From author ZA

Wealth distribution by race and ...

11.23.08 | 18:44 PM From author Valerie J

Nymph's Trading Daily Trading Diary

04.13.09 | 01:10 AM From author Trading Nymph

Robotic Stock Trading Software

11.05.09 | 14:31 PM From author jm.4769

more forums

Q. Pages 78 - 80 of the healthcare ...

11.08.09 | 08:45 AM Asked by Karen Schubeck

A. Type II Diabetes in obese patients is
wrecking our health care system.
Overall, more than $1 in every $10 spent
on health care in the United States goes
toward treating Diabetes. Blood glucose
test strips alone can cost about a
dollar each and if you're testing
several times a day every day, the costs
can add up pretty quickly. XOMA has the
first drug "XOMA 052" in the last 10yrs
which will significantly impact this
industry and you would no longer require
daily insulin injections or insulin at
all, for that matter. This would save
the government billions, search on that
one and you'll make a fortune. The
government cannot continue to pay these
kinds of rising diabetes costs, when
there is an alternative which is so safe
and so effective which just became
patented in Europe.